Delivery Order SPE2DB24D6041-SPE2DB25FKBWC
Award Date
3/26/25
Potential Completion Date
3/27/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,976.80 firm fixed-price delivery order is for the supply of the drug febuxostat 80 mg tablets. The contract has an ultimate completion date of December 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,562,906 units of Febuxostat 40 mg tablets. The firm-fixed-price delivery order contract, valued at $1,061.78, has a completion date of November 28, 2023. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,559.71 firm fixed-price delivery order is for the supply of febuxostat 40 mg tablets, a medication used to treat gout. The contract has an ultimate completion date of March 20, 2024 and was awarded on March 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,913.99 Firm Fixed Price Delivery Order contract is for the supply of febuxostat 40 mg tablets. The contract is not set aside and is a child award under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,661,577 units of febuxostat 40 mg tablets. The award, valued at $2,066.16, is a Firm Fixed Price Delivery Order with an ultimate completion date of December 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization registered in the System for Award Management...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $2,255.44 to provide the drug Febuxostat 40 mg Tablet 30s. The contract has an ultimate completion date of February 14, 2024 and was awarded on February 13, 2024 by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Febuxostat 80 mg tablets. The $1,328.20 firm fixed-price award has a period of performance through July 2024. Amerisourcebergen provides a wide range of essential pharmaceutical and medical products to federal agencies and healthcare programs, including military treatment facilities and veterans' hospitals. This delivery order is part of a...
This federal contract award, valued at $1,563.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4565032605 - FEBUXOSTAT 80 MG TABLET 30S, with a completion date of July 1, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 40 mg Febuxostat tablets. The $3,981.14 firm fixed-price contract has an ultimate completion date of October 15, 2024. AmerisourceBergen holds several significant Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of pharmaceutical and medical supplies. This specific delivery order is part of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,797.97, is for the delivery of febuxostat 40 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of April 1, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...